近年来，随着中国国内市场的逐步饱和，中国药企开始加速走向国际化，寻求更广阔的市场空间。而在这个过程中，创新药的研发成为关键一环。
16 日，罗氏集团董事会主席施万在上海表示，十几年前，创新药在中国与其他国家上市的时间差较大，但现在这个差距已经缩小了很多。
他指出，目前中国药企在创新药研发方面已经取得了显著成果，包括研发出了多个具有国际竞争力的创新药，并在国际市场上进行了广泛的推广。
“我们非常看好中国药企在未来出海的发展前景。通过加强研发，提高创新水平，中国药企将有望在国际市场上占据更有竞争力的地位。”施万表示。
据业内人士透露，中国药企正在加大力度，努力提高研发水平，以满足国内市场需求和海外市场的需求。
新闻翻译：
Chinese pharmaceutical companies are speeding up their “go-out” strategy, and the gap between innovative drug research and development is gradually narrowing.
Keywords: Chinese pharmaceutical companies, go-out, innovative drugs, research and development
News content:
In recent years, with the gradual saturation of the Chinese market, Chinese pharmaceutical companies have accelerated their journey towards internationalization, seeking a broader range of market spaces. However, in this process, the research and development of innovative drugs have become a key factor.
On October 16th, the board of directors of the Roche Group, Mr. Severin Schwan, in Shanghai said that about a decade ago, the time difference between the approval and listing of innovative drugs in China and other countries was significant, but now this gap has narrowed significantly.
He pointed out that currently, Chinese pharmaceutical companies have made significant achievements in the research and development of innovative drugs, including the development of multiple innovative drugs that have gained international competitiveness and have been widely promoted in international markets.
“We are very optimistic about the development prospects of Chinese pharmaceutical companies in the future. By increasing research and development and improving innovation, Chinese pharmaceutical companies will likely take a more competitive position in international markets.” Schwan said.
According to industry sources, Chinese pharmaceutical companies are working hard to improve their research and development level in order to meet the demand of both domestic and foreign markets.
【来源】http://www.chinanews.com/cj/2023/10-16/10094988.shtml
Views: 1